Table 1.
The baseline characteristics of enrolled patients and HDs.
| Variables | NK Cell Function Group | NK Cell Phenotype Group | ||
|---|---|---|---|---|
| Patients | HDs | Patients | HDs | |
| Number of cases | 19 1 | 6 | 29 | 24 |
| Age (year) | 38 (17–51) | 53 (36–57) | 39 (17–62) | 47 (31–65) |
| Gender (male/female) | 12/7 | 5/1 | 11/18 | 16/8 |
| t(8;21)/RUNX1::RUNX1T1 (n) | 19 | NA | 25 | NA |
| inv(16)/CBFB::MYH11 (n) | 0 | NA | 4 | NA |
| c-KIT mutation (n) | 10 | NA | 14 | NA |
| WBC count (×109/L) | 14.5 (4.0–50.1) | 6.5 (3.7–6.9) | 9.9 (0.85–90.8) | 6.1 (3.7–7.9) |
| Hemoglobin (g/L) | 73.0 (36.0–130.0) | 155.5 (127.0–161.0) | 75.0 (43.0–144.0) | 149.5 (121.0–185.0) |
| Platelet count (×109/L) | 28.0 (8.0–106.0) | 204.0 (137.0–303.0) | 27.0 (3.0–134.0) | 223.5 (137.0–336.0) |
| BM blast percentage (%) | 46.0 (23.0–90.0) | NA | 55.0 (12.0–89.0) | NA |
1 The continuous variables were represented by the median (range) and the categorical variables were represented by the number of cases.